Drug Type Small molecule drug |
Synonyms (-)-(1R,3R,4S)-menthol, (-)-Menthol, (1alpha,2beta,5alpha)-5-methyl-2(1-methylethyl)cyclohexanol + [12] |
Mechanism TRPA1 inhibitors(Transient receptor potential cation channel subfamily A member 1 inhibitors), TRPM8 agonists(Transient receptor potential cation channel subfamily M member 8 agonists), κ opioid receptor antagonists(Kappa opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (20 Jan 1986) |
Regulation- |
Molecular FormulaC10H20O |
InChIKeyNOOLISFMXDJSKH-KXUCPTDWSA-N |
CAS Registry2216-51-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Levomenthol | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Intestinal Diseases | Phase 2 | JP | 01 Oct 2014 |
Not Applicable | 32 | oxbiavybps(jbxuwiogsf) = cyhxyxmlfn fzyznhnfuf (bostetolex, vzwfaabllt - myjnkkbqfj) View more | - | 27 Apr 2015 |